Call for Abstract

9th Diabetologists Conference , will be organized around the theme “Prevention and Management of Diabetes Through Advanced Technologies”

Diabetologists 2016 is comprised of 12 tracks and 121 sessions designed to offer comprehensive sessions that address current issues in Diabetologists 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Diabetes often referred as diabetes mellitus, describes a group of metabolic diseases. Diabetes occurs when there is a dis-balance between the demand and production of the hormone insulin. There are different types of diabetes and all types of diabetes are treatable. Pathophysiology of  diabetes leads to autoimmune disease and its also known as IDDM,  whereas it also leads to the Peripheral insulin resistance and also known as NIDDM or “adult onset” diabetes. Pathophysiology of gestational diabetes is also one of the types when there are excessive counter-insulin hormones of pregnancy. Every few years, the  metabolic syndromes like diabetes is  re-evaluates by community  the current recommendations for the classification, diagnosis, and screening of diabetes, reflecting new information from research and clinical practice which in turns help in understanding current prevention and treatment options and cost effectiveness in treatment and prevention of Diabetes.

Related Conference of Diabetes Pathophysiology :

International Conference on Aleternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting  Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany; 5th World Congress on Controversies to Consensus in  obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015, Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria; Endocrinology Conferences October 10-12, 2016 Manchester, UK.

  • Track 1-1Diabetes: Type 1 and Type 2
  • Track 1-2Monogenic Forms of Diabetes
  • Track 1-3Paediatric diabetes
  • Track 1-4Immune Intervention diabetes
  • Track 1-5Prediabetes
  • Track 1-6Diabetes in children
  • Track 1-7Idiopathic
  • Track 1-8Latent autoimmune diabetes of adults
  • Track 1-9Autoimmune Diabetes Mellitus
  • Track 1-10Gestational Hyperglycaemia and Diabetes
  • Track 1-11Neonatal Diabetes

It is important to diagnose the diabetes and to evaluate it clinically as soon as possible. The expertise recommends that everyone aged 45 and over should be clinically analysed for diabetes, and if the results are normal. But due to change in food habbit, Childhood diabetes is also becomming common amongs childrens. Traditionally, diagnosis of diabetes should be made by using a blood glucose meter and finger prick, or by urine glucose test in clinical laboratory. Testing enables health care providers to find and treat diabetes before complications occur and to find and treat prediabetes, which can delay or prevent type 2 diabetes from developing. To treat the disease of diabetes, insulin is produced using recombinant DNA technology.  The an A1C test, also called the haemoglobin A1c, HbA1c, or glycohemoglobin test ,a fasting plasma glucose (FPG) test, an oral glucose tolerance test (OGTT) can be used for diagnosis. The gene therapy is also one of the best methods to be considered for treating the diabetes.  Clinical trial on animal and various  latest research on diabetes are being practised.

Related Conference for Diagnostics and Clinical Analysis:

International Conference on Aleternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, United States; 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria, Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE

  • Track 2-1Anti-diabetic agents or Anti Hyperglycemia
  • Track 2-2Type 2 risk indicator tests.
  • Track 2-3Prediabetes and Metabolic Syndrome
  • Track 2-4Oral glucose tolerance test
  • Track 2-5Novel Paradigms in diabetes
  • Track 2-6Glutamic Acid Decarboxylase Autoantibodies
  • Track 2-7Gene Therapy
  • Track 2-8GAD antibody test
  • Track 2-9Fasting Plasma Glucose
  • Track 2-10Diabetes screening tests
  • Track 2-11Diabetes Insipidus
  • Track 2-12C-peptide tests
  • Track 2-13Clinical Trials on Animal Models
  • Track 2-14Clinical Diagnosis and Laboratory Tests
  • Track 2-15Hyperglycemia

Case study is an important part for research and treatment. Clinical case study aims directly improve global health outcomes and share clinical knowledge using case reports to convey important best practice messages. If case study is done then the advanced medical technologies like transplantation, holistic treatment can be used more rapidly in hospitals and with the more study in Glycemic index and load  we can find the diseases or problem like Cortisol . Even with this, we can know the number of people by using Diabetes Statistics having  diseases and can find by advances in diabetes cure. Drug mechanism can be known and along with these new technologies as well pharmacotherapy can be done. Clinical case study done in   medical diabetes  could leads to find innovative way for treating the diabetes.

Related Conference for Clinical Case Study :

Endocrinology Conferences October 10-12, 2016 Manchester, UK, International Conference on Aleternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, United States; 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria

  • Track 3-1Carbohydrate counting
  • Track 3-2Diabesity
  • Track 3-3Glycemic control in the hospital
  • Track 3-4Blood glucose monitoring in intensive care units
  • Track 3-5Stem cell therapy
  • Track 3-6Transplantation
  • Track 3-7Holistic treatment
  • Track 3-8Clinical Trials and New biomarkers under development
  • Track 3-9Pharmacotherapy in treatment of diabetes
  • Track 3-10Glycemic load
  • Track 3-11Glycemic index
  • Track 3-12Self-Monitoring of Blood Glucose

Diabetes can affect every part of the body, including the skin. In fact, such problems are sometimes the first sign that a person has diabetes. Luckily, most skin conditions can be prevented or easily treated if caught early. Some of these problems are skin conditions anyone can have, but people with diabetes get more easily. These include bacterial infections, fungal infections, and itching. Other skin problems happen mostly or only to people with diabetes. These include diabetic dermopathy, necrobiosis lipoidica diabeticorum, diabetic blisters, and eruptive xanthomatosis.

  • Track 4-1Acanthosis Nigricans
  • Track 4-2Diabetic Dermopathy
  • Track 4-3Necrobiosis Lipoidica Diabeticorum
  • Track 4-4Allergic Reactions
  • Track 4-5Diabetic Blisters
  • Track 4-6Eruptive Xanthomatosis
  • Track 4-7Digital Sclerosis
  • Track 4-8Disseminated Granuloma Annulare

Diabetes is a metabolic disorder  in which the person has high blood glucose (blood sugar), either because insulin production is inadequate. Long-term complications of diabetes like diabetic cholestrol develop gradually. The longer we have diabetes, and the less controlled our blood sugar, the higher the risk of complications to skin & immune sytem , cardiovascular diseases, and nerve damage. Diabetes and alcohol will cause your blood sugar to rise and alcohol has a lot of calories. Patients with diabetes will typically experience various complications like Diabetic Macular Oedema , people with diabetes also facing one of the major complication that is diabetic foot having problems like ulceration, polyuria, infection or neuropathic osteroarthropathy, polydipsia, Alzheimer's disease, polyphagia and even more. Diabetes being the one of the causes of death in world and results into other health complication caused like blindness and kidney failure.

Related conference for Diabetes and its complications:

International Conference on Aleternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, United States; 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria

Diabetes is a metabolic disorder  in which the person has high blood glucose (blood sugar), either because insulin production is inadequate. Long-term complications of diabetes like diabetic cholestrol develop gradually. The longer we have diabetes, and the less controlled our blood sugar, the higher the risk of complications to skin & immune sytem , cardiovascular diseases, and nerve damage. Diabetes and alcohol will cause your blood sugar to rise and alcohol has a lot of calories. Patients with diabetes will typically experience various complications like Diabetic Macular Oedema , people with diabetes also facing one of the major complication that is diabetic foot having problems like ulceration, polyuria, infection or neuropathic osteroarthropathy, polydipsia, Alzheimer's disease, polyphagia and even more. Diabetes being the one of the causes of death in world and results into other health complication caused like blindness and kidney failure.

Related conference for Diabetes and its complications:

International Conference on Aleternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, United States; 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria, Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE

  • Track 5-1Diabetes and Cardiovascular disease
  • Track 5-2Retinopathy
  • Track 5-3Polyuria
  • Track 5-4Polyphagia
  • Track 5-5Polydipsia
  • Track 5-6Neuropathy
  • Track 5-7Nephropathy
  • Track 5-8Diabetic Foot Care
  • Track 5-9Diabetic Macular Oedema
  • Track 5-10Diabetic ketoacidosis
  • Track 5-11Diabetic Gastroparesis
  • Track 5-12Ethnicity
  • Track 5-13Diabetes and Endocrinology
  • Track 5-14Genetic defects in insulin action

Diabetic market is a rapidly growing segment with numerous products at different stages of clinical pipeline and others at different phases of industry life cycle. The industrial products cure the diabetes and the thyroid disorder , some times health complication also gets effected by diabetes which directly or indirectly effects one of our organ like  pancreas causing Pancreatic Disorder  , and these effects leads to discover the different   includes the different metabolic pathways leads to increase in the death rate in the world . The record of death rate can be well maintained by using the diabetes statistic and these records can be easily kept in data bases having information related to medical devices which are being used with the help of bioinformatics tools. Diabetic market research includes both research and opinion research having systematic gathering and  interpretation of information like insulin pump, biomarkers and about individuals or organizations using statistical and analytical methods , the various companies have antidiabetic drugs which is being widely used in hospitals and patients suffering from diabetes and techniques of the applied social sciences to gain insight or support decision making.  Disease incidences are escalating rapidly across the globe due to which high unmet demand has been created and pharmaceutical companies are trying to provide efficient medical care to patients. Number of diabetes drugs for treatment is increasing every year due to which their market shares are expected to increase further in coming years.

Related conference for diabetes Research Market:

International Conference on Aleternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, United States; 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria, Endocrinology Conferences October 10-12, 2016 Manchester, UK

  • Track 6-1Lancing Devices & Lancets
  • Track 6-2Artificial and bio-artificial pancreas
  • Track 6-3Bariatric surgery & obesity
  • Track 6-4Continuous Glucose Monitoring
  • Track 6-5Development of insulin pump
  • Track 6-6Human Insulins and Analogues
  • Track 6-7Novel Paradigms in diabetes
  • Track 6-8Pharmaceutical Drug
  • Track 6-9Pharmacotherapy
  • Track 6-10Recent advances in Diabetic drugs
  • Track 6-11Diagnostic and Monitoring Supplies
  • Track 6-12Syringes & Pen Needles
  • Track 6-13Needles & Lancet Disposal
  • Track 6-14Antidiabetic medicines or drugs

Diabetes drug delivery is a mature field which provides lots of opportunities to the pharmaceutical companies to market their products which cure the problem related to endcrinology. Various companies are manufacturing different drugs for diabetic patients and the health complication caused due to it .Some of the advanced products like insulin pumps, sensors, biomarkers and Innovation seem to be the key to success because it is quite mature and without novel functionality. Telemedicines and softwares related to Increased investments in research and development segment are expected to introduce competitive pharamaceutical products at cost effective prices in short time. This latest research on diabetes showas that the diabetes drug market segment would be filled with innovative products that would be able to offer better diabetes management which will protect from  swollen pancreas  to patients.

Related conference for Diabetes Drug Delivery in market :

International Conference on Aleternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, United States; 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria, Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE

  • Track 7-1New medications for treatment of diabetes
  • Track 7-2Telemedicine software and other technologies
  • Track 7-3Informatics in the service of medicine
  • Track 7-4Devices focused on diabetic preventions
  • Track 7-5New Insulin analogues
  • Track 7-6New Insulin delivery systems: Inhaled, transderma, implanted devices
  • Track 7-7Implantable pumps and sensors
  • Track 7-8Glucose sensors (invasive and non-invasive)
  • Track 7-9Insulin pumps
  • Track 7-10New technologies and drugs for treating obesity

The main goal of diabetes management is to restore metabolism of carbohydrate to as close to a normal state as possible. To achieve this goal, individuals with an absolute deficiency of insulin require insulin replacement therapy, which is given through injections or an insulin pump. Insulin resistance, in contrast, can be corrected by dietary modifications and exercise. Diabetes is a metabolic disease which can be corrected by transplantation techniques. This different type of diabetic disease can be prevented by islet transplantation or even by artificial pancreas transplantation and some time Hypoglycemia Awareness  and checking sugar level regulary is necessary. Prevention during pregnancy is very crucial and meanwhile we should know the way for managing the gestational diabetes. Diabetes management are to prevent or treat the many complications that can result from the disease itself and from its treatment.The metabolism boosters  gets changes. Modern approaches to diabetes primarily rely upon dietary and lifestyle management, often combined with regular on-going blood glucose level monitoring. Diet management allows control and awareness of the types of nutrions entering the digestive system, and hence allows indirectly, significant control over changes in blood glucose levels

Hypoglycemia Awareness

Related conference for Diabetes: Prevention and Management :

Endocrinology Conferences October 10-12, 2016 Manchester, UK, International Conference on Aleternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, United States; 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria

  • Track 8-1 Hypoglycemia Responses
  • Track 8-2Cholesterol Screenings
  • Track 8-3Pregnancy and Management
  • Track 8-4Pediatric diabetes
  • Track 8-5Reverse Diabetes
  • Track 8-6Nutrition Therapy
  • Track 8-7Yoga and diabetes
  • Track 8-8Herbs, Supplements and Alternative Medicines
  • Track 8-9Self-Monitoring of Blood Glucose
  • Track 8-10Hypoglycemia Awareness
  • Track 8-11Dietary Modifications and Exercise
  • Track 8-12Insulin Replacement Therapy
  • Track 8-13Life Style Modification
  • Track 8-14Biochemical and Human Nutrition

The concept of and new discovery and emerging therapies like reverse diabetes  for the treatment of diabetes has expanded in recent years.There is a lot of latest research on diabetes happening all around the world and the latest includes  Some very rare forms of diabetes are caused by single gene mutations. They are called "monogenic" forms of diabetes and new research is opening the door to specific treatments for these patients. With the advanced  type1 diabetes treatment  various devices e.g. insulin pumps which is used for the administration of insulin , rapid HbA1c monitoring, insulin pen, biomarkers, biostator, artificial pancreas and etc. are formed for the treatment. Various pharmaceutical companies are making drugs for improving the lives of those with the disease. Number of innovation and treatment are increasing with the increase in research work by Research and development department in various sectors and endocrinology is getting treatement with these devices. Continuous Glucose Monitoring (CGM) is a relatively new technology which has the potential to assist people living with type 1 or type 2 diabetes and treated with insulin to achieve the goal of optimum control of blood glucose.this will remove the diabetes cholestrol.

Related conference for Treatment and Therapy :

International Conference on Aleternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE,  International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, United States; 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria, Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE.

  • Track 9-1Molecular Markers for both metabolic syndrome
  • Track 9-2Inflammatory markers and Type 2 diabetes
  • Track 9-3Pharmacotherapy in treatment of diabetes
  • Track 9-4New drug treatments and devices for diabetes
  • Track 9-5Development of insulin pump
  • Track 9-6Development of artificial Beta cells and pancreas
  • Track 9-7Biostator: closed loop system
  • Track 9-8Development of Insulin Pens and Novel Insulin Delivery technique
  • Track 9-9Cell encapsulation

The research on diabetes leads to focus more on the diagnosis and treatment of diseases with the new approaches yet to be discovered or under developments. Maturity onset diabetes of the young, Diabetic Dyslipidemia is one of the major issues for the concern which is due to mutation. Without the pancreas producing this insulin, the sugar will stay in our blood and begin to create serious health issues. High blood sugar can cause blindness, kidney failure, nerve damage, and other organ function problems. There are various metabolic  syndrome  which are to be treated with recent tools for obesity and weight management  is  Bariatric surgery , stem cell therapy. With the development of software’s, now the computational tools i.e bioinformatics are used for the analysis of data e.g. Sequence alignment, microarray analysis and specific tools mentioned.The researcher are also focusing on the metabolism of people with diabetes as it differs to the metabolism of people without diabetes.  In type 2 diabetes, the effectiveness of insulin is reduced and in type 1 diabetes, insulin levels in the body are very low. There is a strong correlation between BMI and body fat. One of the correlates of insulin resistance is the blood fatty acid (FA) level. FA levels are strong predictors of muscle insulin resistance. In diabetes for dummy's, it is vital to get tested regularly to make sure your normal blood sugar levels are safe. In the meantime, diabetes for dummies says to check your blood sugar levels, and know what they are.  Electron microscopy shows decreased mitochondrial size in muscle from individuals with type 2 diabetes.

Related conference for Emerging Focus in Diabetes Research:

International Conference on Aleternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, United States; 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria, Endocrinology Conferences October 10-12, 2016 Manchester, UK

  • Track 10-1Obesity and diabetes
  • Track 10-2Bariatric surgery & obesity
  • Track 10-3Diabetes and Parkinson
  • Track 10-4Diabetic Dyslipidemia
  • Track 10-5Epidemiology of diabetes in geriatric population
  • Track 10-6New technologies for treating obesity
  • Track 10-7Bioinformatics tools and techniques used in diabetes research
  • Track 10-8Drug– or chemical–induced diabetes

Diabetes fall into the categories of type 1, type 2, and diabetes that occurs during pregnancy (gestational diabetes). However, up to 5% of cases have other specific causes and include diabetes that results from the mutation of a single gene. Maturity onset diabetes in the young (MODY) that is inherited as an autosomal dominant trait is an uncommon cause of diabetes that may be mistaken for type 2 diabetes. The clustering of cardiovascular risk factors such as obesity and diabetes , hypertension, dyslipidaemia and glucose intolerance in the same persons has been called the metabolic or insulin-resistance syndrome.The more typical, common and multi-factorial form of Type 2 diabetes results from the interaction between environmental risk factors and predisposing genotype (a combination of genetic variants). (T2D) is characterized by insulin resistance in peripheral tissues like muscle, fat and liver coupled with effects of aging, obesity and reduced exercise  and dysregulated insulin secretion by pancreatic betacells. In T2D, the pancreatic disorder like  pancreatic beta cells become progressively less able to secrete sufficient insulin to maintain normal carbohydrate and lipid homeostasis.

Related conference For Genetics of diabetes:

International Conference on Aleternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, United States; 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria,Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE

  • Track 11-1Genetic Defects of Beta Cell Function
  • Track 11-2MODY and its types
  • Track 11-3Genetic Syndromes Associated with Diabetes
  • Track 11-4Genetics of Metabolic Syndrome
  • Track 11-5Recent advances in Genetics of Diabetes
  • Track 11-6Endocrinopathies

The National Institute of Health estimates that obesity and related complications such as diabetes are our nation's chief health concern. However, while most people tend to think of diabetes and obesity as a developed market problem, the two issues are spreading quite rapidly across the globe. Roughly, four out of five people suffering from diabetes are now located in developing markets. China alone, has 92.3 million diabetic citizens, while India’s diabetic population is over 50 million. Overall, there are nearly 371 million people across the globe that suffer from diabetes and plenty more that are in pre-diabetic stages.All in all, the growing number of people who suffer from the disease will push the global spending for diabetes to reach $48 to $53 billion by 2016. The diabetes sub-sector is the largest market for medical devices. Analysts estimate that in the U.S. alone will reach $20 billion by next year. Investors can play the device angle through several avenues from syringe manufacturers like Retractable Technologies  and West Pharmaceutical, glucose monitors through Becton, Dickinson and Company  or cutting edge insulin pumps through Insulet Corporation.

Related Conferences :

International Conference on Aleternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria, Endocrinology Conferences October 10-12, 2016 Manchester, UK